ADORA2A and early-onset autosomal dominant Alzheimer disease: In conclusion, the results of these studies show that CBD, through A2AR activation, exerts anti-inflammatory effects in models of multiple sclerosis, hypoxic-ischemic damage, Alzheimer’s disease and hepatic encephalopathy (Table 1).